Analyst David Nierengarten works at WEDBUSH and is covering the Healthcare, Communication Services sectors with 598 price targets and ratings documented since 2011 spanning on 50 stocks.
David Nierengarten's average stock forecast success ratio is 48.06% with an average time for price targets to be met of 194.61 days.
Most recent stock forecast was given on TSVT, at 18-May-2023.
Analyst best performing recommendations are on AVRO (AVROBIO, INC).
The best stock recommendation documented was for KPTI (KARYOPHARM THERAPEUTICS INC) at 3/2/2020. The price target of $25 was fulfilled within 1 day with a profit of $2.72 (9.81%) receiving and performance score of 98.12.
Average potential price target upside
Currently, out of the existing stock ratings of David Nierengarten - 7 which are a Buy (87.5%), 1 which are a Hold (12.5%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Sell
30
$11.45 (61.73%)
31
9 days ago
1/6 (16.67%)
$13.4 (43.31%)
46
Hold
29
$10.45 (56.33%)
32
19 days ago
6/10 (60%)
$16.69 (39.35%)
61
Buy
45
$26.45 (142.59%)
19 days ago
2/5 (40%)
$38.81 (80.71%)
229
Hold
35
4 months 25 days ago
0/1 (0%)
$11.78 (50.73%)
Buy
38
$19.45 (104.85%)
35
6 months 22 days ago
0/2 (0%)
$9.48 (35.55%)
